Trials / Sponsors / Qinglei Gao
Qinglei Gao
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neo Ovarian Cancer | Phase 2 | 2025-12-30 |
| Completed | Research on Nutritional Risk Indexes and Inflammatory Indicators in Postoperative Complications and Prognosis Epithelial Ovarian Cancer | — | 2012-01-01 |